Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

BD Ultra-Fine Insulin Syringe 1mL Recalled by Becton Dickinson & Company Due to Nonsterile syringe potentially exposing the patient to pathogenic...

Date: February 1, 2023
Company: Becton Dickinson & Company
Status: Ongoing
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Becton Dickinson & Company directly.

Affected Products

BD Ultra-Fine Insulin Syringe 1mL, 12.7mm, 29G-Insulin Syringes are designed for administering insulin in the treatment of diabetes mellitus. Catalog Number: 326719

Quantity: 80,500 units

Why Was This Recalled?

Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection.

Where Was This Sold?

This product was distributed nationwide across all 50 states.

Affected (51 states)Not affected

About Becton Dickinson & Company

Becton Dickinson & Company has 169 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report